Abstract
Dopamine can be released in the substantia nigra from the dendrites of nigrostriatal dopaminergic neurones, to be involved there in the self-regulation of the dopaminergic cells, to control the release of neurotransmitters from nigral afferent fibres and to influence the activity of nigral non-dopaminergic cells.
Similar content being viewed by others
References
Bjorklund, A. & Lindvall, O. Brain Res. 83, 531–537 (1975).
Hamori, J., Pasik, P. & Pasik, T. Adv. Neural. 14, 149–162 (1975).
Kreutzberg, G. W., Toth, L. & Kaiya, H. Adv. Neurol. 14, 269–282 (1975).
Ramon-Moliner, E. Adv. Neurol. 14, 135–148 (1975).
Shepherd, G. M. Scient. Am. 238, 92–102 (1978).
Juraska, J. M., Wilson, C. J. & Groves, P. M. J. comp. Neurol. 172, 585–600 (1977).
Sotelo, C. J. Ultrastruct. Res. 36, 824–841 (1971).
Parizek, J., Hassler, R. & Bak, I. J. Z. Zellforsch. mikrosk. Anat. 115, 137–148 (1971).
Cuello, A. C. & Kelly, J. S. Br. J. Pharmac. 59, P 527–528 (1977).
Cuello, A. C. & Iversen, L. L. in Interactions between Putative Neurotransmitters in the Brain (eds Garattini, S., Pujol, J. F. & Samanin, R.) 127–149 (Raven, New York, 1978).
Sotelo, C., Javoy, F., Agid, Y. & Glowinski, J. Brain Res. 58, 269–290 (1973).
Hattori, T., Fibiger, H. C. & McGeer, P. L. J. comp. Neurol. 162, 487–504 (1975).
Pickel, V. M., Joh, T. H., Field, P. M., Becker, C. G. & Reis, D. J. J. Histochem. Cytochem. 23, 1–12 (1975).
Hökfelt, T., Johansson, O., Fuxe, K., Goldstein, M. & Park, D. Medbiol. Illust. 54, 427–453 (1976).
Pickel, V. M., Joh, T. H. & Reis, D. J. J. Histochem. Cytochem. 24, 792–806 (1976).
Ljungdahl, A., Hökfelt, T., Nilsson, G. & Goldstein, M. Neuroscience 3, 945–976 (1978).
Hattori, T., McGeer, P. L. & McGeer, E. G. Brain Res. 170, 71–83 (1979).
Javoy, F., Hamon, M. & Glowinski, J. Eur. J. Pharmac. 10, 178–188 (1970).
Hornykiewicz, O. Wien. klin. Wschr. 75, 309–312 (1963).
Versteeg, D. H. G. Van der Gugten,, J., De Jong, W. & Palkovitz, M. Brain Res. 113, 563–574 (1976).
Geffen, L. B., Jessell, T. M., Cuello, A. C. & Iversen, L. L. Nature 260, 258–260 (1976).
Mercer, L., Del Fiacco, M. & Cuello, A. C. Experientia 35, 101–103 (1979).
Wilson, C. J., Groves, P. M. & Fifkova, E. Expl Brain Res. 30, 161–174 (1977).
Korf, J., Zieleman, M. & Westerink, B. H. C. Nature 260, 257–258 (1976).
Korf, J., Zieleman, M. & Westerink, B. H. C. Brain Res. 120, 184–187 (1977).
Westerink, B. H. C. J. Pharm. Pharmac. 31, 94–99 (1979).
Fadda, F., Argiolas, A., Stefanini, A. & Gessa, G. L. Life Sci. 21, 411–418 (1977).
Kebabian, J. W., Saavedra, J. M. & Axelrod, J. J. Neurochem. 28, 795–801 (1977).
Hefti, F., Lienhart, R. & Lichtensteiger, W. Nature 263, 341–343 (1976).
Pericic, D. & Walters, J. R. J. Pharm. Pharmac. 28, 527–529 (1976).
Wuerthele, S. M., Friedle, N. M. & Moore, K. E. J. Neurol. Transm. 45, 117–127 (1979).
Westerink, B. H. C. & Korf, J. Eur. J. Pharmac. 40, 131–136 (1976).
Tagerud, S. E. O. & Cuello, A. C. Neuroscience 4, 2021–2029 (1979).
Hefti, F. & Lichtensteiger, W. J. Neurochem. 30, 1217–1230 (1978).
Hefti, F. & Lichtensteiger, W. Neurosci. Lett. 10, 65–70 (1978).
Silbergeld, E. K. & Walters, J. R. Neurosci. Lett. 12, 119–126 (1979).
Paden, C., Wilson, C. J. & Groves, P. M. Life Sci. 19, 1499–1506 (1976).
Starr, M. S. Eur. J. Pharmac. 48, 325–328 (1978).
Reubi, J. C., Emson, P. C., Jessell, T. M. & Iversen, L. L. Naunyn Schmiedebergs Archs Pharmak. 304, 271–275 (1978).
Kerwin, E. & Pycock, C. Br. J. Pharmac. 64, 428 (1978).
Kerwin, E. & Pycock, C. Eur. J. Pharmac. 54, 93–98 (1979).
Nieoullon, A., Chéramy, A. & Glowinski, J. Nature 266, 375–377 (1977).
Wong, R. K. S., Prince, D. A. & Basbaum, A. I. Proc. natn. Acad. Sci. U.S.A. 76, 986–990 (1979).
Fukuda, J. & Kameyama, M. Brain Res. 182, 191–197 (1980).
Llinas, R. & Hess, R. Proc. natn. Acad. Sci. U.S.A. 7, 2520–2523 (1976).
Michelot, R., Leviel, V., Giorguieff-Chesselet, M. F., Chéramy, A. & Glowinski, J. Life Sci. 24, 715–724 (1979).
Chéramy, A., Michelot, R., Nieoullon, A., Leviel, V. & Kerdelhué, B. in Catecholamines: Basic and Clinical Frontiers Vol. 2 (eds Usdin, E., Kopin, I. J. Barchas, J.) 1098–1100 (Pergamon, New York, 1979).
Chéramy, A., Nieoullon, A. & Glowinski, J. Eur. J. Pharmac. 48, 281–295 (1979).
Nieoullon, A., Chéramy, A. & Glowinski, J. Brain Res. 145, 69–84 (1978).
Nieoullon, A., Chéramy, A. & Glowinski, J. Brain Res. 148, 143–152 (1978).
Leviel, V., Chéramy, A. & Glowinski, J. Nature 280, 236–239 (1979).
Greenfield, S., Chéramy, A., Leviel, V. & Glowinski, J. Nature 284, 355–357 (1980).
Nieoullon, A., Chéramy, A. & Glowinski, J. Nature 269, 340–342 (1977).
Bunney, B. S. & Aghajanian, G. K. Nature new Biol. 245, 123–125 (1973).
Aghajanian, G. K. & Bunney, B. S. Naunyn-Schmiedebergs Archs Pharmak. 297, 1–7 (1977).
Groves, P. M., Wilson, C. J., Young, S. J. & Rebec, G. V. Science 190, 522–529 (1975).
Groves, P. M., Young, S. J. & Wilson, C. J. Neuropharmacology 15, 755–762 (1976).
Reisine, T. D., Nagy, J. I., Fibiger, H. C. & Yamamura, H. I. Brain Res. 169, 209–214 (1979).
Quik, M., Emson, P. C. & Joyce, E. Brain Res. 167, 355–365 (1979).
Murrin, L. C., Gale, K. & Kuhar, M. J. Eur. J. Pharmac. 60, 229–235 (1979).
Nagy, J. I., Lee, T., Seeman, P. & Fibiger, H. C. Nature 274, 278–281 (1978).
Chéramy, A., Nieoullon, A., Michelot, R. & Glowinski, J. Neurosci. Lett. 4, 105–109 (1977).
Nieoullon, A., Chéramy, A., Leviel, V. & Glowinski, J. Eur. J. Pharmac. 53, 289–296 (1979).
DiChiara, G., Porceddu, M. L., Spano, P. F. & Gessa, G. L. Brain Res. 130, 374–382 (1977).
Garcia-Munoz, M., Nicolau, N. M., Tulloch, I. F., Wright, A. K. & Arbuthnott, G. W. Nature 265, 363–365 (1977).
Bunney, B. S. & Aghajanian, G. K. Naunyn-Schmiedebergs Archs Pharmak 304, 255–261 (1978).
Carlsson, A. & Lindqvist, M. Acta pharmac. tox. 20, 140–144 (1963).
Chéramy, A. et al. Brain Res. 155, 404–408 (1978).
Bunney, B. S. & Aghajanian, G. K. in The Basal Ganglia (ed. Yahr M. P.) 249–267 (Raven, New York, 1976).
Dray, A. Neuroscience 4, 1407–1439 (1979).
Reubi, J. C. & Sandri, C. Neurosci. Lett. 13, 183–188 (1979).
Prémont, J. et al. FEBS Lett. 68, 99–104 (1976).
Spano, P. F., DiChiara, G., Tonon, G. C. & Trabucchi, M. J. Neurochem. 27, 1565–1568 (1976).
Gale, K., Guidotti, A. & Costa, E. Science 195, 503–505 (1977).
Dray, A. & Straughan, D. W. J. Pharm. Pharmac. 28, 400–405 (1976).
Ruffieux, A. & Schultz, W. Nature 285, 240–241 (1980).
Brown, L. L. & Wolfson, L. I. Brain Res. 140, 188–193 (1978).
Wechsler, L. R., Savaki, H. E. & Sokoloff, I. J. Neurochem. 32, 15–22 (1979).
Reubi, J. C., Iversen, L. L. & Jessell, T. M. Nature 268, 652–654 (1977).
Van der Heyden, J. A. M., Venema, K. & Korf, J. J. Neurochem. 34, 119–125 (1980).
Jessell, T. M. Proc. int. Soc. Neurochem. 6, 220 (1977).
Chéramy, A., Chesselet, M. F., Leviel, V. & Glowinski, J. (in preparation).
Héry, F. et al. Brain Res. 193, 143–151 (1980).
Jaffé, E. H. & Cuello, A. C. (in preparation).
Kramer, S. G. Invest. Ophthalmol. 71, 438–52 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cheramy, A., Leviel, V. & Glowinski, J. Dendritic release of dopamine in the substantia nigra. Nature 289, 537–543 (1981). https://doi.org/10.1038/289537a0
Issue Date:
DOI: https://doi.org/10.1038/289537a0
- Springer Nature Limited
This article is cited by
-
Substantia nigral dopamine transporter uptake in dementia with Lewy bodies
npj Parkinson's Disease (2023)
-
A genetically encoded sensor measures temporal oxytocin release from different neuronal compartments
Nature Biotechnology (2023)
-
Paraquat as an Environmental Risk Factor in Parkinson’s Disease Accelerates Age-Related Degeneration Via Rapid Influx of Extracellular Zn2+ into Nigral Dopaminergic Neurons
Molecular Neurobiology (2019)
-
Extracellular Zn2+ Influx into Nigral Dopaminergic Neurons Plays a Key Role for Pathogenesis of 6-Hydroxydopamine-Induced Parkinson’s Disease in Rats
Molecular Neurobiology (2019)
-
Baicalin reverses the impairment of synaptogenesis induced by dopamine burden via the stimulation of GABAAR–TrkB interaction in minimal hepatic encephalopathy
Psychopharmacology (2018)